Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Head & Neck 1Genitourinary 1Gastrointestinal 1

Conditions

Melanoma 137Carcinoma, Renal Cell 52Kidney Neoplasms 43Leukemia, Myeloid, Acute 38Neoplasm Metastasis 37Leukemia 33Lymphoma 30Breast Neoplasms 26Ovarian Neoplasms 24Lymphoma, Non-Hodgkin 22Carcinoma, Non-Small-Cell Lung 22Skin Neoplasms 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Neuroblastoma 18Lymphoma, Follicular 18Pancreatic Neoplasms 16Lymphoma, Mantle-Cell 16Leukemia, Lymphocytic, Chronic, B-Cell 16Stomach Neoplasms 14Neoplasms 14Myelodysplastic Syndromes 14Colorectal Neoplasms 13Multiple Myeloma 12Lymphoma, Large B-Cell, Diffuse 12Lymphoma, B-Cell, Marginal Zone 12Hodgkin Disease 12Congenital Abnormalities 12Uterine Cervical Neoplasms 11Lymphoma, Large-Cell, Immunoblastic 11Lung Neoplasms 11

Interventions

human papillomavirus vaccine, L1 type 16, 18 40Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 32Papillomavirus Vaccines 24Human Papillomavirus Recombinant Vaccine nonavalent 12Vaccines 11Blood Specimen Collection 10Data Collection 9Colposcopy 9Human Papillomavirus DNA Tests 8Specimen Handling 7Radiotherapy, Intensity-Modulated 7Cisplatin 7Surveys and Questionnaires 6Educational Status 6Early Intervention, Educational 6Carboplatin 6Vaginal Smears 5Vaccines, Synthetic 5Methods 5Engerix-B 4fludarabine 3epigallocatechin gallate 3artesunic acid 3artemisinin 3Watchful Waiting 3Polymerase Chain Reaction 3Patient Navigation 3Paclitaxel 3Observation 3Mass Screening 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Papillomavirus Infections × aldesleukin × Clear all
NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
224 enrolled 15 charts
Gynecologic

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

NCT01585428 2018-03-07

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
29 enrolled 12 charts
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡